基本信息
浏览量:212
职业迁徙
个人简介
Our research seeks to understand signal transduction pathways that control cell survival and death in normal and cancer cells. Based on newly discovered oncogenic signaling mechanisms, we employ a chemical biology approach to gain further insights into the molecular basis of cancer and to develop small molecule modulators for drug discovery and translational research.
Survival signaling pathway studies. We are interested in identifying mechanisms that couple survival signaling to the apoptotic machinery. One such mechanism is mediated by the 14-3-3 protein family. 14-3-3 suppresses apoptosis in part through binding to death-promoting proteins such as ASK1 and Bad. We are taking steps to dissect the roles of 14-3-3 in mitogenic and apoptotic signaling pathways. Because of its role in mitogenic signaling and tumorigenesis, 14-3-3 is used as a probe for identifying novel regulatory proteins that promote or suppress tumorigenesis.
Small molecule modulator identification for probe and drug discovery. One hallmark of cancer is the upregulation of cell survival. We are designing mechanism-based bioassays for high throughput and high content screening (HTS/HCS) of compounds for signaling modulators, such as 14-3-3 and ASK1 inhibitors. Such compounds will be developed as probes for mechanistic studies and for drug discovery.
Translational research. To translate our basic understanding of survival signaling into clinical settings, we collaborate with physician scientists to develop novel therapeutic strategies for the prevention and treatment of cancer. In addition, we collaborate with chemists to develop new anticancer agents that can modulate survival pathways with the hope of moving more effective therapeutics into the clinic.
Survival signaling pathway studies. We are interested in identifying mechanisms that couple survival signaling to the apoptotic machinery. One such mechanism is mediated by the 14-3-3 protein family. 14-3-3 suppresses apoptosis in part through binding to death-promoting proteins such as ASK1 and Bad. We are taking steps to dissect the roles of 14-3-3 in mitogenic and apoptotic signaling pathways. Because of its role in mitogenic signaling and tumorigenesis, 14-3-3 is used as a probe for identifying novel regulatory proteins that promote or suppress tumorigenesis.
Small molecule modulator identification for probe and drug discovery. One hallmark of cancer is the upregulation of cell survival. We are designing mechanism-based bioassays for high throughput and high content screening (HTS/HCS) of compounds for signaling modulators, such as 14-3-3 and ASK1 inhibitors. Such compounds will be developed as probes for mechanistic studies and for drug discovery.
Translational research. To translate our basic understanding of survival signaling into clinical settings, we collaborate with physician scientists to develop novel therapeutic strategies for the prevention and treatment of cancer. In addition, we collaborate with chemists to develop new anticancer agents that can modulate survival pathways with the hope of moving more effective therapeutics into the clinic.
研究兴趣
论文共 394 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 879-879
Frances M Bashore,Vittorio L Katis,Yuhong Du,Arunima Sikdar, Dongxue Wang,William J Bradshaw, Karolina A Rygiel,Tina M Leisner,Rod Chalk, Swati Mishra, C Andrew Williams,Opher Gileadi,
bioRxiv : the preprint server for biologyno. 2 (2024): e0293548-e0293548
Michelle K. Tenggara, Seo-Ho Oh, Catherine Yang, Hardik K. Nariya, Amanda M. Metz,Amit A. Upadhyay, Dedeepya R. Gudipati, Lizheng Guo, Emily G. McGhee,Kiran Gill,Elise G. Viox,Rosemarie D. Mason,
Cell Reportsno. 3 (2024): 113948-113948
Journal of Biological Chemistryno. 3 (2023): 103340-103340
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)
引用0浏览0引用
0
0
JOURNAL OF BIOLOGICAL CHEMISTRYno. 3 (2023): S152-S152
引用0浏览0引用
0
0
Lijuan Bai, Xin Li, Yang Yang, Rui Zhao,Elshaddai Z White,Alira Danaher,Nathan J Bowen,Cimona V Hinton,Nicholas Cook,Dehong Li,Alyssa Y Wu,Min Qui,
Translational oncology (2023): 101707-101707
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn